PFIZER INC (PFE)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for PFE
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PFE | Director | 73 | ["Significant achievements in medicine, healthcare and academia","Faculty member at NYU Langone Medical Center for more than 25 years","Renowned immunologist and molecular biologist","Member of the National Academy of the Sciences","Member of the National Academy of Medicine","Fellow of the American Academy of Arts and Sciences","Fellow of the American Academy of Microbiology","Scientific co-founder and Advisory Board Member of Vedanta Biosciences and Immunai, Inc."] | ["Governance","Audit","Regulatory and Compliance","Science and Technology","Governance Committee","Regulatory and Compliance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Dan R. Littman, MD, Ph.D., serves as a Professor in the Department of Microbiology at NYU Grossman School of Medicine and is a member of the board at Pfizer Inc. Born in 1953, Littman has made significant contributions to the field of immunology and infectious diseases. He earned his MD and Ph.D. from Washington University School of Medicine in St. Louis and completed his postdoctoral training at the Whitehead Institute for Biomedical Research at MIT. Littman's research focuses on the molecular mechanisms of immune system regulation, particularly in the context of HIV and other viral infections. His work has been instrumental in advancing our understanding of how the immune system responds to pathogens and has led to the development of novel therapeutic strategies.
In 2018, Littman was recognized for his outstanding contributions to science and medicine, receiving multiple prestigious awards. He is a member of the National Academy of Sciences, the National Academy of Medicine, and a fellow of the American Academy of Arts and Sciences and the American Academy of Microbiology. Littman's expertise extends beyond academia, as he serves on various scientific advisory boards, including being a founding scientific advisory board member of Vedanta Biosciences and a scientific co-founder and advisory board member of Immunai, Inc. His involvement in these organizations underscores his commitment to translating scientific discoveries into practical applications for improving human health.
At Pfizer Inc., Littman serves as an independent board member, bringing his extensive knowledge in science and technology to the company's governance. He is a member of the Science and Technology Committee, where he contributes to the development and oversight of Pfizer's research and development strategies. Littman's role on the board is crucial in ensuring that the company remains at the forefront of scientific innovation and maintains high standards of regulatory compliance. His dual expertise in academia and industry positions him uniquely to guide Pfizer in its mission to develop life-saving medications and vaccines.